Bolivia Medical Device Regulatory Framework Overview: AGEMED Single-Authority System

1. Key takeaways

Pre-market approval of medical devices in Bolivia is administered by a single authority, the Bolivian National Agency for Medicines and Health Technologies (AGEMED). The legal foundation rests on Article 2 of the Medicines Law, Ley N° 1737 of December 17, 1996, and on Decreto Supremo N° 2905 of September 21, 2016, which created AGEMED. Any medical device must obtain a sanitary registration (Registro Sanitario) before it can be marketed in Bolivia. The certificate is valid for 5 years from the date of issuance, imported devices carry a DI code prefix, and domestically manufactured devices carry a DN code prefix. Foreign manufacturers cannot file an application in their own name: the application must be initiated by a Bolivian local company authorized by ministerial resolution, using Form 027. This rule of a single local-entry point is, in the experience of GRZAN on Bolivian projects, the first and the most far-reaching structural constraint a manufacturer will encounter. It shapes distributor selection, contract drafting, cost planning, and the entire timeline of a market-entry program, because every downstream obligation, from labeling to customs clearance, hangs on the identity of the local registration holder.

In practice, this single-authority design has two visible effects. Because AGEMED is the only body that grants the sanitary registration, every question about the dossier, from the language of the label to the acceptance of a free sale certificate, has a single addressee, and answers can be obtained from one source. At the same time, because the local authorized company files the application in its own name, the manufacturer’s control over the registration runs through contract law rather than through the application itself, which is why the distribution and representation agreements deserve as much regulatory attention as the technical file. GRZAN treats the contractual layer and the dossier layer as one program in Bolivia, sequenced together from the first project meeting rather than handled by different workstreams that meet only at submission.

2. Legal basis

3. Expert insights

Insight one: a young agency operating older rules. AGEMED was only established in 2016, built on the foundations of UNIMED (the Unit for Medicines and Health Technologies) and CONCAMYT (the National Quality Control Laboratory for Medicines and Toxicology). Yet the device registration rules it applies today come from the Medical Device Sanitary Registration Manual, a document written before AGEMED even existed. The Bolivian official procedures portal (gob.bo) still lists that manual, alongside Resolución Ministerial N° 0265 of May 25, 2018, as the legal basis for the registration procedure for imported devices. The practical implication is direct: copying a Brazilian or Colombian dossier template into Bolivia is a wasted effort. The real document checklist is written in the manual, not in the experience of neighboring markets, and reviewers in La Paz will judge the dossier against the manual’s own section numbering.

Insight two: a single regulator does not mean a single window. AGEMED governs the sanitary registration, but a patient monitor with a wireless module must additionally pass type approval at ATT, the Bolivian telecommunications and transport regulator, and devices involving metrological functions must deal with IBMETRO. These tracks run in parallel, not in series. If any one of them is omitted from the project plan, the omission surfaces at the customs clearance stage, when the shipment is already in the country and commercial pressure is at its highest. Planning all tracks from day one costs far less than untangling them at the border.

Insight three: the DI and DN code prefixes are the first visible indicator of the registration’s nature. Imported devices carry DI, domestic production carries DN. Procurement bodies and tender committees often use the prefix to read the structure of the supply chain behind a product. Companies designing their channel strategy should treat the prefix as a piece of commercial information rather than a purely technical field, because it signals whether the product on the shelf is locally manufactured or imported, and through whom the registration is held.

Insight four: the five-year certificate makes timing a compliance variable. Because the sanitary registration is valid for 5 years from issuance and must be filed through a local authorized company, the moment of issuance defines the renewal horizon, the price list exposure, and the tender calendar for the product. Filing too early relative to the commercial launch consumes certificate life; filing too late pushes the launch past the observation round of the review. Aligning the submission date with the launch plan is therefore a genuine regulatory decision, not an administrative detail, and it should be made jointly by the regulatory and commercial teams before the dossier is drafted.

4. Practical recommendations

1. Define the group before defining the class. Bolivia registers by group: one group, one certificate. The grouping table is in Anexo 2 of the manual. If the catalog mapping is not done before the application is prepared, the number of registrations, and therefore the cost, will almost certainly be underestimated.
2. Weight due diligence on the local entity more heavily than commercial negotiation. Because the sanitary registration is bound to the certificate holder, the cost of correcting a wrong importer choice is far higher in Bolivia than in neighboring markets.
3. Design the schedule to include one round of observations. Do not treat the issuance timeline stated in the manual as the end-to-end cycle; the observation-response round must be built into the plan.

5. Verification checklist

• □ Confirm whether the product falls within the category of dispositivos médicos listed in Article 2 of Ley N° 1737
• □ Confirm that the prospective Bolivian partner holds a valid ministerial resolution authorization and a certificate of enterprise in force
• □ Confirm whether the product contains a wireless module or metrological function, and assess the parallel ATT / IBMETRO obligations
• □ Download the current version of the Medical Device Sanitary Registration Manual from the AGEMED website (agemed.gob.bo) and check the version date of the manual
• □ Confirm whether the target products have been mapped into groups according to Anexo 2

Regulatory information verified as of October 29, 2026.

GRZAN supports manufacturers, importers, and authorized representatives with medical device registration in Bolivia, covering dossier preparation, local entity coordination, and regulatory strategy. Contact info@grzanglobal.com for project inquiries.